• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2008 年年鉴:危重病医学-肾脏病学。

Year in review 2008: Critical Care--nephrology.

机构信息

Department of Pediatric Cardiosurgery, Bambino Gesù Hospital, Piazza S, Onofrio, 4 00165 Rome, Italy.

出版信息

Crit Care. 2009;13(5):227. doi: 10.1186/cc7961. Epub 2009 Oct 21.

DOI:10.1186/cc7961
PMID:19863769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2784338/
Abstract

We summarize original research in the field of critical care nephrology accepted or published during 2008 in Critical Care and, when considered relevant or directly linked to this research, in other journals. Three main topics have been identified for a rapid overview. (1) The classification of acute kidney injury, with particular attention to differences and similarities between the RIFLE and AKIN classifications. (2) Fluid balance in patients requiring renal replacement therapy (RRT) has been shown as an independent risk factor for mortality in critically ill patients: current evidence and uncertainties are described. (3) Management of anticoagulation during RRT has been explored by several researchers in 2008: diagnosis of heparin-induced thrombocytopenia, the use of tirofiban and optimal anticoagulation during drotrecogin A activated treatment have been evaluated.

摘要

我们总结了 2008 年在《重症监护》和其他相关期刊上发表的重症监护肾脏病学领域的原始研究。为了快速概述,我们确定了三个主要主题。(1)急性肾损伤的分类,特别关注 RIFLE 和 AKIN 分类之间的差异和相似之处。(2)在需要肾脏替代治疗(RRT)的患者中,液体平衡已被证明是危重病患者死亡的独立危险因素:描述了当前的证据和不确定性。(3)2008 年,几位研究人员探讨了 RRT 期间的抗凝管理:肝素诱导的血小板减少症的诊断、替罗非班的使用以及在激活治疗中使用 drotrecogin A 时的最佳抗凝。

相似文献

1
Year in review 2008: Critical Care--nephrology.2008 年年鉴:危重病医学-肾脏病学。
Crit Care. 2009;13(5):227. doi: 10.1186/cc7961. Epub 2009 Oct 21.
2
Year in review 2012: Critical Care--Nephrology.2012年回顾:重症监护——肾脏病学
Crit Care. 2013 Nov 22;17(6):246. doi: 10.1186/cc13126.
3
Year in review 2009: Critical Care--nephrology.2009 年年鉴:危重病医学-肾脏病学。
Crit Care. 2010;14(6):241. doi: 10.1186/cc9277. Epub 2010 Nov 5.
4
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.在患有Ⅱ型肝素诱导的血小板减少症和肾功能损害的患者进行体外循环期间,使用肝素和血小板糖蛋白IIb-IIIa拮抗剂替罗非班进行抗凝。
Anesthesiology. 2001 Feb;94(2):245-51. doi: 10.1097/00000542-200102000-00013.
5
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.肝素诱导的血小板减少症与体外循环:使用普通肝素和糖蛋白IIb/IIIa抑制剂替罗非班进行抗凝,并成功使用重组活化凝血因子VII治疗因持续血小板阻滞导致的鱼精蛋白后出血。
Eur J Cardiothorac Surg. 2008 Sep;34(3):687-9. doi: 10.1016/j.ejcts.2008.05.029. Epub 2008 Jun 24.
6
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
Ann Thorac Surg. 2000 Dec;70(6):2160-1. doi: 10.1016/s0003-4975(00)01888-9.
7
Two consecutive open heart operations in a small child with heparin-induced thrombocytopenia type II using anticoagulation with heparin and tirofiban.一名儿童因肝素诱导的血小板减少症 II 型连续接受两次心脏直视手术,采用肝素和替罗非班进行抗凝治疗。
Ann Thorac Surg. 2012 Aug;94(2):653-5. doi: 10.1016/j.athoracsur.2011.12.091. Epub 2012 May 10.
8
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy.接受重组人活化蛋白C治疗且需要肾脏替代治疗的严重脓毒症患者的滤过存活时间及血液制品需求量
Crit Care. 2008;12(6):R163. doi: 10.1186/cc7163. Epub 2008 Dec 18.
9
One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
J Thorac Cardiovasc Surg. 2001 Dec;122(6):1254-5. doi: 10.1067/mtc.2001.118271.
10
Renal replacement therapy and anticoagulation.肾脏替代治疗与抗凝。
Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):387-401. doi: 10.1016/j.bpa.2017.08.005. Epub 2017 Aug 24.

引用本文的文献

1
The implications and management of septic acute kidney injury.脓毒症急性肾损伤的意义与处理。
Nat Rev Nephrol. 2011 Apr;7(4):218-25. doi: 10.1038/nrneph.2011.15. Epub 2011 Mar 1.
2
Year in review 2009: Critical Care--nephrology.2009 年年鉴:危重病医学-肾脏病学。
Crit Care. 2010;14(6):241. doi: 10.1186/cc9277. Epub 2010 Nov 5.

本文引用的文献

1
Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study.严重烧伤合并急性肾损伤患者的持续静静脉血液滤过:一项队列研究
Crit Care. 2009;13(3):R62. doi: 10.1186/cc7801. Epub 2009 May 1.
2
Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis.在严重脓毒症患者血液滤过中,活化的打瑞替加滨(drotrecogin alfa)的抗凝特性。
Crit Care. 2009;13(1):113. doi: 10.1186/cc7684. Epub 2009 Feb 2.
3
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy.接受重组人活化蛋白C治疗且需要肾脏替代治疗的严重脓毒症患者的滤过存活时间及血液制品需求量
Crit Care. 2008;12(6):R163. doi: 10.1186/cc7163. Epub 2008 Dec 18.
4
Acute kidney injury in burns: a story of volume and inflammation.烧伤后急性肾损伤:容量与炎症的故事
Crit Care. 2008;12(6):192. doi: 10.1186/cc7106. Epub 2008 Nov 25.
5
Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?替罗非班能否预防心源性休克患者在持续肾脏替代治疗期间的血小板丢失?
Crit Care. 2008;12(6):193. doi: 10.1186/cc7083. Epub 2008 Nov 24.
6
Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.在一个常见需求、低发病率的单中心,使用临床4T评分和微粒凝胶免疫测定法对肝素诱导的血小板减少症进行及时诊断和管理。
Br J Haematol. 2008 Dec;143(5):721-6. doi: 10.1111/j.1365-2141.2008.07401.x.
7
Correlation between the AKI classification and outcome.急性肾损伤分类与预后之间的相关性。
Crit Care. 2008;12(6):R144. doi: 10.1186/cc7123. Epub 2008 Nov 20.
8
Year in review 2007: Critical Care--nephrology.2007年回顾:重症监护——肾脏病学
Crit Care. 2008;12(5):230. doi: 10.1186/cc6952. Epub 2008 Oct 14.
9
Acute kidney injury is common, parallels organ dysfunction or failure, and carries appreciable mortality in patients with major burns: a prospective exploratory cohort study.急性肾损伤很常见,与器官功能障碍或衰竭相关,并且在重度烧伤患者中具有相当高的死亡率:一项前瞻性探索性队列研究。
Crit Care. 2008;12(5):R124. doi: 10.1186/cc7032. Epub 2008 Oct 10.
10
Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.在一项随机前瞻性开放盲法试点研究中,替罗非班在持续肾脏替代治疗期间可减少血小板丢失。
Crit Care. 2008;12(4):R111. doi: 10.1186/cc6998. Epub 2008 Aug 29.